The small and large intestine

16 The small and large intestine






Surgical anatomy and physiology



Anatomy and function of the small intestine


The small bowel extends from the pylorus to the ileocaecal valve and ranges in length from 3 to 9 metres. The jejunum, which comprises two-fifths of the small intestine, is of wider calibre than the ileum, and the diameter of the gut lumen narrows progressively from the duodenojejunal flexure to the ileocaecal valve. The small bowel mucosa is supported on a



strong submucosa and comprises a single layer of columnar cells in a villiform structure that dramatically increases the absorptive surface area. Columnar glandular epithelium is interspersed with mucus-secreting cells, Paneth cells and amine precursor uptake and decarboxylation (APUD) cells derived from the neural crest. Between the inner layer of circular muscle and the outer longitudinal layer runs Auerbach’s myenteric plexus, which comprises vagal parasympathetic fibres and sympathetic fibres from the lesser and greater splanchnic nerves. This plexus controls orderly propulsive contractions of the muscular layers of the gut wall. The sympathetic nervous system mediates the sensation of visceral pain, and a submucosal plexus (Meissner’s plexus) of autonomic nerves innervates the glandular cells in the epithelium.


The small intestine is supplied by the superior mesenteric artery, which runs in the root of the small bowel mesentery, supplying the bowel by a series of arterial arcades (Fig. 16.1). These midgut vessels communicate with the coeliac axis through the pancreaticoduodenal arcade. The superior mesenteric supply also communicates with that of the inferior mesenteric artery by contributing to the colonic marginal artery through the left branch of the middle colic artery, which joins to the ascending branch of the left colic artery. Venous blood drains via the superior mesenteric vein to the portal vein. Lymphoid aggregates in the submucosa (Peyer’s patches) are more numerous in the ileum, and lymph drains to regional nodes in the root of the mesentery before passing to the cisterna chyli.



The principal function of the small bowel is absorption of amino acids, short peptides, sugars and fats, as well as minerals, vitamins and other micronutrients. Its secretory and digestive functions supplement those of the upper gastrointestinal tract. The mucosa is thrown into circular folds (plicae semilunares) and is carpeted by finger-like villi, giving an absorptive area of 200–500 m2. Some 5–8 litres of fluid enter the jejunum each day, of which only 1–2 litres normally pass to the colon.



Anatomy and function of the large intestine and appendix


The principle function of the large intestine is water absorption, particularly the proximal colon. The left colon and rectum act as a reservoir until defaecation is appropriate. Mucus is secreted as a lubricant. The large bowel mucosa consists of columnar epithelium interspersed with mucus-secreting goblet cells. The villi are shorter than those of the small intestine, and crypts pass down to the muscularis mucosa, which is supported by a strong submucosa. The large bowel extends from the ileocaecal valve to the upper anal canal (approximately 1.6 metres). The caecum is a blind pouch at the most proximal part of the large bowel. The transverse and sigmoid colon are mobile because they have a mesentery, whereas ascending and descending colon are only partially peritonealized. The true rectum is demarcated by coalescence of the taeniae coli of the sigmoid colon to form a continuous outer muscular tube. The upper third of the rectum has peritoneal cover on its front and sides, the middle third is peritonealized only anteriorly and the lower third is wholly extraperitoneal.


The inferior and superior mesenteric arteries supply the colon and anastomose via a marginal artery (Fig. 16.2) that allows collateral supply in the event of arterial occlusion, but at the splenic flexure this arterial communication may be tenuous. The superior rectal artery is the continuation of the inferior mesenteric artery, supplying the rectum and anastomosing with the middle and inferior rectal arteries (branches of the internal iliac arteries). The inferior mesenteric vein drains into the splenic vein. Lymph channels run along the course of the arterial supply, draining to epicolic and paracolic nodes close to the bowel wall, and to regional nodes at the origin of the superior and inferior mesenteric vessels (Fig. 16.2). Lymph from the rectum drains upwards to superior rectal and inferior mesenteric nodes, whereas anal canal lymph drains to inguinal nodes. Knowledge of the lymphatic drainage has considerable relevance to surgical lymphadenectomy performed as part of radical cancer clearance, as well as to radiotherapy for rectal and anal cancers.



The appendix is lined by colonic epithelium but has no known function in humans. The submucosa contains prominent lymphoid follicles in childhood that regress in adolescence. In older patients, the lumen may be obliterated by fibrosis. The appendix projects from the medial wall of the caecum some 2 cm below the ileocaecal junction as the taeniae coli converge on the root of the appendix.



Clinical assessment of the small and large intestine



History


Painful contraction of the midgut (supplied by the superior mesenteric artery: small bowel, right and part transverse colon) due to obstruction or inflammation results in peri-umbilical colic. Disorders affecting the large bowel, i.e. hindgut (supplied by the inferior mesenteric artery: from distal transverse colon to rectum), are frequently associated with ill-defined lower abdominal colicky pain. Nausea, vomiting and pain are early and predominant features of many small bowel disorders, particularly obstruction. In contrast, large bowel conditions may present with poorly defined features including abdominal distension and altered bowel habit; vomiting is a late feature. Normal bowel frequency ranges from one motion in 3 days, up to 3 motions/day. The passage of blood or mucus per rectum is a common feature of large bowel disease. It is important to differentiate ‘outlet-type’ bleeding from sinister blood loss, when the blood is mixed with the stool and there may be associated altered bowel habit or tenesmus. Outlet bleeding is typically bright red and may be present only on toilet paper or spattered in the pan, separate from the stool. There may be associated perianal pain, due to fissure or prolapsed piles. Blood originating from the distal bowel is usually bright red, whereas blood coming from the upper gastrointestinal tract is usually altered by gut bacteria and becomes black (melaena). Weight loss, malaise and anaemia are common non-specific features of intestinal disease.




Investigation of the luminal gastrointestinal tract


Investigation of diarrhoeal illnesses should include stool culture with sensitivities, tests for Clostridium difficile toxin as well as cysts, ova and parasites. Imaging modalities for small bowel investigation comprise plain radiography, magnetic resonance imaging (MRI) enteroclysis, barium follow-through, small bowel enema, computed tomography (CT), fibreoptic enteroscopy, capsule video-endoscopy, labelled white cell radionuclide scanning and labelled red cell radionuclide scanning. The terminal ileum can be inspected at colonoscopy, double-contrast barium enema frequently allows visualization of the terminal ileum, and a pneumocolon technique can also be used with barium follow-through to obtain double-contrast views of the terminal ileum. Duodenal biopsy undertaken at upper gastrointestinal video-endoscopy to identify the characteristic subtotal villous atrophy is the gold standard investigation of suspected coeliac disease. However, coeliac disease is frequently diagnosed by serum ELISA assays for auto-antibodies, including anti-endomysial, IgA anti-gliadin or tissue transglutaminase (tTG) antibodies. Tests of absorptive capacity are now rarely used. Bacterial overgrowth can be assessed using the glucose breath test, 14C-xylose and 14C-glycocholate breath tests. Small bowel aspiration can be carried out by nasojejunal tube or at enteroscopy for bacterial culture. Faecal calprotectin is a non-specific test of intestinal inflammation that can be used to monitor inflammatory bowel disease activity.


Direct inspection of the large bowel includes proctoscopy, rigid sigmoidoscopy, flexible sigmoidoscopy and colonoscopy. These techniques allow biopsy and snare removal of colorectal polyps using cauterizing diathermy. Plain radiography is used extensively in the emergency situation but is seldom of value in elective investigation. CT double contrast radiography of the large bowel has largely superseded double contrast barium enema to allow inspection of the mucosa. CT also has considerable utility in the assessment of the acute abdomen. CT of chest, abdomen and pelvis is routinely used in staging of colon and rectal cancer, along with MRI for rectal cancer. Positron emission tomography (PET) after administering a fluoride18 labelled tracer (fluorodeoxyglucose) that is metabolized by tumours (FDG-PET CT) has recently been introduced, although it is generally reserved for staging of complex colorectal cancer cases being considered for more major multiorgan resections. Colonic transit can be assessed in cases of suspected megacolon or slow-transit constipation by administering radio-opaque markers to estimate large bowel transit.



Principles of operative intestinal surgery


The crucial role of the small bowel in maintaining nutrition requires that resectional surgery should aim to retain the maximum possible length of bowel. Ileocaecal resection for Crohn’s disease may result in gallstone formation and megaloblastic anaemia, owing to poor absorption of bile salts and vitamin B12. Conversely, loss of the entire large bowel can be tolerated with little impact on nutritional status, but occasionally water and salt depletion can occur, especially in hot climates.


Small intestinal anastomoses heal well, owing to their excellent blood supply and rich submucosal arteriolar plexus. Small bowel content clears after 12 hours of fasting and so no specific bowel preparation, apart from fasting, is required for planned small bowel resection. The large intestine microcirculation consists of a series of small end-arteries, which, combined with the presence of faeces with a high density of bacterial colonization, results in poor anastomotic healing compared to those of the small intestine. This produces a higher anastomotic leak rate for colocolic or colorectal anastomoses.


In the emergency setting there is an increased risk of anastomotic leakage and so there is a lower threshold for the formation of a stoma. In specialist centres, every effort is made to reconstitute large bowel continuity in both elective and emergency resectional surgery. In emergency surgery for left-sided colonic obstruction or perforation, a total colectomy with anastomosis of the ileum to the rectum may be considered to avoid a colorectal anastomosis in the presence of faecal loading. Segmental left-sided resection and the formation of a colostomy (Hartmann’s operation) avoids an anastomosis, but many specialist colorectal surgeons prefer left-sided resection with primary anastomosis.


There has been a move away from mechanical bowel preparation for elective large bowel resections because of lack of beneficial effect in research trials. Low-residue diet prior to surgery has an important place, while antibiotic prophylaxis is essential, comprising a single dose of a broad-spectrum antibiotic to cover coliform bacteria, in combination with metronidazole to cover anaerobic bacteria.



Disorders of the appendix




Appendiceal tumours






Inflammatory bowel disease


In view of the similarities in clinical presentation and in some aspects of management, it is useful to discuss Crohn’s disease and ulcerative colitis together (Table 16.1). Ulcerative colitis affects the colon and rectum exclusively, whereas Crohn’s disease may affect any part of the gastrointestinal tract. Inflammation is restricted to the mucosa in ulcerative colitis but transmural inflammation is a hallmark of Crohn’s disease. There are also important implications for prognosis, as surgery for ulcerative colitis is curative, whereas Crohn’s disease frequently follows a relapsing course, despite medical or surgical intervention.


Table 16.1 Clinical features of Crohn’s disease and ulcerative colitis.



















































  Crohn’s disease Ulcerative colitis
Incidence 5–7 per 100 000 and rising 10 per 100 000 and static
Extent May involve entire gastrointestinal tract Limited to large bowel
Rectal involvement Variable Almost invariable
Disease continuity Discontinuous (skip lesions) Continuous
Depth of inflammation Transmural Mucosal
Macroscopic appearance of mucosa Cobblestone, discrete deep ulcers and fissures Multiple small ulcers, pseudopolyps
Histological features Transmural inflammation, granulomas (50%) Crypt abscesses, submocosal chronic inflammatory cell infiltrate, crypt architectural distortion, goblet cell depletion, no granulomas
Presence of perianal disease 75% of cases with large bowel disease; 25% of cases with small bowel disease 25% of cases
Frequency of fistula 10–20% of cases Uncommon
Colorectal cancer risk Elevated risk (relative risk = 2.5) in colonic disease 25% risk over 30 years for pancolitis
Relationship with smoking Increased risk, greater disease severity, increased risk of relapse and need for surgery Protective, first attack may be preceded by smoking cessation within 6 months


Crohn’s disease


Although originally described as a disease affecting the terminal ileum, any part of the gastrointestinal tract can be involved, from mouth to anus. In 50% of cases both small and large bowel are involved, whereas in 25% of cases large bowel alone is affected. The incidence is increasing in developed countries and the annual incidence rate is currently 5–7 cases per 100 000 in the UK population. At the time of initial clinical presentation, the features of Crohn’s disease may be indistinguishable from those of ulcerative colitis. Indeed, in cases of colonic Crohn’s disease, it may be difficult to differentiate the two conditions, even after resection and histological assessment.


Cigarette smoking is the single most important risk factor for developing the disease, and is associated with increased disease severity and frequency of relapse, as well as the need for surgical intervention. However there is a substantial heritable component to the disease. There is also evidence for the involvement of immunological factors and the gut bacterial flora in the pathogenesis of Crohn’s disease. Recently, over 30 genetic loci have been identified that each contribute a small effect in host–bacteria interaction. These include CARD15 (NOD2), dysregulation of adaptive immunity (IL23R), and deficient autophagy (ATG16L1, IRGM).




Clinical features


Crohn’s disease is a chronic disorder with exacerbations, remissions and a varied clinical presentation. Continuous or episodic diarrhoea is associated with recurring abdominal pain and tenderness, lassitude and fever. Declining general health, malabsorption and weight loss, with failure to thrive and to reach developmental milestones, are common in affected children.


Examination may reveal malnutrition and there may be a palpable abdominal mass. There may be features of subacute intestinal obstruction, and this may be due to active disease, stricturing of ‘burnt-out’ disease, or adhesions from previous surgical intervention. Fistula formation occurs in 20% of patients with small and large bowel disease, but less in those with disease restricted to the large bowel. Fistulae may communicate with adjacent loops of bowel, other viscera (e.g. bladder, vagina) or the skin. External fistulae may result from surgical intervention and commonly involve the anterior abdominal wall or perineum (Fig. 16.4). Abscesses can result from chronic bowel perforation, but free perforation is relatively uncommon because the inflamed segment usually adheres to surrounding structures. Although less common than in ulcerative colitis, toxic dilatation can complicate colonic disease. Fulminant Crohn’s colitis is shown in Figure 16.5; deep ulcers and fibrosis with mucosal oedema and inflammation can be seen.




It is essential to consider malignancy in patients with long-standing Crohn’s disease, with or without symptoms. There is an elevated risk of colorectal adenocarcinoma: 2.5-fold overall and 4.5-fold for colonic disease, with a 10-year cumulative risk following diagnosis of 2.9%. Evidence is limited that surveillance provides protection and many patients with longstanding colonic Crohn’s eventually come to colectomy. Crohn’s disease is also associated with ∼︀30-fold excess risk of small bowel adenocarcinoma, but because that cancer is rare, the absolute risk only amounts to 0.2% at 10 years and 2.2% at 25 years after diagnosis.


25% of patients with small bowel Crohn’s disease and 75% with large bowel disease have troublesome anal lesions, including abscess, fistula, fissures, ulceration, oedematous skin tags, anorectal stricturing. Anal fissures are often multiple and indolent, and extend to involve any part of the perineum, including the vagina or scrotum. Systemic manifestations of Crohn’s disease include anterior uveitis, iritis, polyarthropathy, ankylosing spondylitis, liver disease (e.g. sclerosing cholangitis) and erythema nodosum. Terminal ileal involvement may result in gallstones, with increased incidence following ileocaecal resection.



Investigations


Assessment of nutritional status, including serial weight measurement, is essential. Anaemia may be due to: iron deficiency from chronic blood loss and rarely due to malabsorption; a normocytic anaemia of chronic disease; macrocytic anaemia from vitamin B12 or folate malabsorption. Elevated acute-phase proteins such as C-reactive protein are useful in monitoring disease, though not specific for diagnostic purposes. Until recently, the diagnosis was most frequently made on barium follow-through: typical features are shown in Figure 16.6 – rose-thorn ulcers, long irregular terminal ileal stricture at the site of previous ileocaecal resection. Active disease produces radiological evidence of thickening, luminal narrowing and separation of loops, and is often associated with mucosal ulceration, deep fissuring ulcers and cobblestone appearance. Skip lesions and fistula formation may be apparent. However, MRI enteroclysis (image enhanced by administering oral osmotically active agent – e.g. PEG) has progressively become the investigation of choice (Fig. 16.7), which also has the advantage of limiting radiation exposure. Rectal examination, proctoscopy, sigmoidoscopy and colonoscopy determine disease extent and biopsy of inflamed bowel is mandatory. Newer investigative techniques include video-capsule endoscopy (Fig. 16.8), enteroscopy, and CT colonography. Double-contrast barium enema still has a place for assessing disease extent and delineation of fistulae.






Management




Surgical management


Many patients with Crohn’s disease undergo surgery at some stage of their disease course and multiple operations are common. There are four main categories of indications for surgical management of Crohn’s disease:




Modern surgical principles are to preserve bowel length whenever possible, by employing a conservative approach to bowel resection and liberal use of stricturoplasty (longitudinal enterotomy with transverse anastomosis of strictured bowel) to enlarge the gut lumen. In all cases, length of small bowel remaining should be measured and documented. Radical surgery is not appropriate because the risk of recurrence is determined by the disease natural history rather than wide surgical clearance. Disease resurgence is common following small bowel resection but is less than 20% in colonic disease. In the initial phases of colonic Crohn’s disease, segmental resection is preferred to bypass of affected segments. However, many such patients eventually undergo proctocolectomy and permanent ileostomy. In perianal Crohn’s disease, loculated pus must be drained and radical surgery should be avoided, as the disease tends to recur. Simple fistulae may be laid open, but long-term drainage Setons are widely used for complex fistulae involving sphincter muscle. Complex reconstructions such as rectal advancement flaps tend to be avoided.




Ulcerative colitis


The annual incidence of ulcerative colitis is ∼︀10/100 000 population in Westernized countries but rare in developing countries. The aetiology is incompletely understood, but genetic, immunological and dietary factors all play a part. The disorder may affect any age group but peak incidence is in early adulthood. In the majority of cases, the disease is contiguous, affecting the rectum and extending proximally (see Table 16.1). In 5% of cases, it is segmental and the rectum is occasionally spared. There is substantial risk of colorectal adenocarcinoma in cases with pancolitis. Although ulcerative colitis is primarily a disease of the large bowel, systemic manifestations (iritis, polyarthritis, sacroiliitis, hepatitis, erythema nodosum, pyoderma gangrenosum) can occur. Primary sclerosing cholangitis (PSC) affects 2–5% of cases of ulcerative colitis; it tends to indicate severe disease and predicts complications. Patients with PSC may develop liver failure and require liver transplantation.



Pathology


The characteristic feature of ulcerative colitis is inflammation restricted to the mucosa and submucosa of the large bowel. In severe episodes, there may be full-thickness involvement with inflammatory infiltrate. Abscesses develop at the base of the colonic crypts, which burst and coalesce to form crypt abscesses. These undermine the mucosa, resulting in ulceration (Fig. 16.9) and oedema of the intervening mucosa, which may form inflammatory pseudopolyps. Histologically, as well as ulceration and crypt abscesses, there is chronic inflammatory cell infiltrate, crypt architectural distortion and goblet cell depletion, but granulomas are absent. The colon loses its haustrations and becomes thick and rigid. Stricturing is uncommon and its presence should raise the possibility of Crohn’s disease. There can be difficulty in distinguishing ulcerative colitis from Crohn’s colitis both pathologically and clinically, when the term ‘indeterminate colitis’ is used to denote uncertainty. There may even be migration from one disease entity to the other. There are important implications for surgical treatment, since ileo-anal pouch should be avoided in cases of Crohn’s colitis.




Clinical features


Ulcerative colitis characteristically runs a relapsing/remitting course, although some patients may have a chronic continuous variant. In some cases, the initial attack is fulminant, and toxic dilatation with exacerbation of abdominal and systemic symptoms may occur at any time. Diarrhoea with the passage of mucus and blood is typical of relapse. Abdominal pain and tenderness may be present and intermittent pyrexia is common. Passage of 10–15 or more stools each day is not unusual in acute severe exacerbations. As well as increased faecal frequency, incapacitating faecal urgency is a distressing problem degrading quality of life for many patients.


Careful rectal examination should detect anal complications such as fissure, fistula and haemorrhoids, which are present in 25% of cases. The rectal mucosa often feels thick and boggy. Sigmoidoscopy and biopsy is the key investigation and reveals a red, granular mucosa with contact bleeding. In the early stages of disease, the only sign on sigmoidoscopy may be loss of the rectal mucosal vessels. As the disease progresses, severe ulceration leads to fulminant colitis, the complications of which include dramatic nutritional depletion, toxic dilatation, perforation and severe bleeding. During an exacerbation, the dilated colon may become paper-thin. Recent population-based studies have revealed that the mortality for all inpatient admissions for ulcerative colitis is ∼︀15% at 3 years, and this emphasizes the potential severity of the disorder.



Investigations


Expert colonoscopy is the mainstay of diagnosis and assessment of disease extent/severity. Endoscopic features of severe acute colitis are shown in Figure 16.10. Barium enema is infrequently used in modern inflammatory bowel disease practice and may risk perforation. Typical changes include loss of haustrations, fluffy granularity of the mucosa, and pseudopolyps. Undermining ulcers may create a double contour to the edge of the colon. Widening of the retrorectal space, due to perirectal inflammation and reduced distensibility of the rectum, is common. In longstanding colitis, the bowel may become short and featureless, resembling a smooth tube (lead-pipe colon). In an acute attack, plain films of the abdomen may reveal a dilated gas-filled colon in which pseudopolyps are evident. When toxic dilatation is suspected, daily plain X-rays are essential to monitor progress (Fig. 16.11). ‘Backwash ileitis’ may produce a dilated and featureless terminal ileum in which the mucosa appears granular. In the acute phase, it is essential to collect stool cultures to exclude supervening bacterial infection and especially C. difficile.




Surveillance colonoscopy has an important place in the management of long-standing colitis to detect dysplasia or supervening cancer.



Management



Medical management


Repeated clinical and laboratory assessment is key during an acute exacerbation to identify those with a severe episode that requires escalation of therapy and/or surgical resection. Daily stool charting, temperature and pulse, along with assays of C reactive protein and albumin are essential. Various criteria are used to identify those with a severe episode and these include Truelove and Witt’s score: stool frequency > 6 × /24h AND any of Hb < 105 g/l, ESR > 30 mm/h, pulse > 90 bpm, T > 37.5°C


Fluid and electrolyte replacement, correction of anaemia, nutritional support, intravenous corticosteroid therapy, and timely surgical intervention are the mainstay of treatment of an exacerbation. High-dose systemic steroids (oral prednisolone, intravenous methylprednisolone or hydrocortisone) are needed during an acute relapse. In fulminant colitis, immunosuppression with ciclosporin A or anti-TNF therapy (e.g. infliximab) may be helpful. Topical steroids delivered by enema or suppository usually control mild attacks of proctocolitis. Long-term aminosalicylates, such as mesalazine or olsalazine, have been shown to reduce the risk of relapse when a patient is in remission. Azathioprine is used for maintenance therapy and may induce remission, though it is not used with such intent. Around 15% of all patients diagnosed with ulcerative colitis will eventually require surgery. The risk varies from 1 in 50 for those with mild proctitis, to 1 in 20 for moderately severe colitis, and 1 in 2 for those with extensive disease.



Surgical management


Indications for surgery in the emergency and elective setting include fulminant colitis that fails to respond to aggressive medical therapy, perforation and toxic dilatation. Patients presenting as an emergency are catabolic, malnourished, immunosuppressed, bacteraemic and septic. Hence, surgical reconstruction in the acute phase is inadvisable and management comprises colectomy and ileostomy as a ‘first-aid’ operation. The rectum is closed over as a stump in the pelvis, or by bringing out the distal end as a mucous fistula. Completion proctectomy and the formation of an ileo-anal pouch are undertaken ∼︀6 months following the emergency operation to allow general health improvements. It is important that patients understand that it is essential to remove the residual rectum because of the elevated risk of rectal cancer over the remaining lifetime.


Indications for surgery in the elective setting include failure of medical management or repeated relapses on medical treatment. Failure to thrive, as reflected in retardation of growth and sexual development in children, or malnourishment and anaemia in adults, is a common indication for operation. The onset of biopsy-proven dysplasia or carcinoma in chronic disease necessitates surgical intervention.


Modern surgical practice comprises restorative proctocolectomy with retention of the anal sphincters and reconstruction by formation of an ileal pouch anastomosed to the upper anal canal. This approach has the benefits of removing all but a tiny cuff of rectal mucosa in the upper anal canal, and also maintaining the ability to defaecate normally. A temporary ileostomy may be required. Median stool frequency is 4–6 liquid/soft motions/day, but the debilitating faecal urgency associated with colitis is eliminated and the overall quality of life is excellent. Where pouch anal anastomosis is not possible, a Koch’s continent ileostomy may be considered. Proctocolectomy and permanent end ileostomy still has an important place in management.




Cancer surveillance in ulcerative colitis


Colorectal cancer risk in long-standing ulcerative colitis is a major factor contributing to surgical decision-making. Carcinoma is typically difficult to detect in colitis, is usually poorly differentiated and has a poor prognosis. Around 2% of all patients will develop cancer at 10 years, 8% at 20 years and 18% at 30 years. In pancolitis, the overall risk is around 25% after 30 years. Early age at first onset (< 15 years), pancolitis, a family history of colorectal cancer and associated PSC are strong cancer risk factors. Cancer surveillance is recommended in the long-term management of patients with chronic ulcerative colitis, and colonoscopy should be performed at 2-yearly intervals (see EBM 16.1). Random biopsies are taken at surveillance colonoscopy, since dysplasia indicates a high risk of cancer. Dysplasia-associated lesion or mass (DALM) is a high-risk indicator of impending, or concurrent, cancer development. Cancer risk for patients with high-grade dysplasia or DALM is > 60% in the next 2 years and so restorative proctocolectomy is recommended. Patients with pancolitis may opt for prophylactic restorative proctocolectomy, especially when ulcerative colitis was diagnosed before the age of 15 years, rather than the uncertainty associated with life-long surveillance.



Disorders of the small intestine



Small bowel neoplasms


Small bowel tumours account for less than 5% of all gastrointestinal neoplasms.




Malignant tumours


Malignant small intestinal tumours are rare and frequently diagnosed late because symptoms are non-specific and so initial presentation may be at laparotomy for small bowel obstruction. In symptomatic cases, imaging modalities include MRI enteroclysis, barium follow-through, CT scan, flexible enteroscopy and video-capsule endoscopy.





Mar 20, 2017 | Posted by in GENERAL SURGERY | Comments Off on The small and large intestine

Full access? Get Clinical Tree

Get Clinical Tree app for offline access